NEW YORK (GenomeWeb) – MDxHealth today announced a scientific agreement with the commercialization arm of the Queensland University of Technology, QUT bluebox, to develop a liquid biopsy epigenetic assay for the early detection of oral cancer.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.